✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Akeso Inc

Common Name
Akeso
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
3,529
Ticker
9926
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Akeso Inc. is a biopharmaceutical company focused on the research, development, and commercialization of innovative, therapeutic solutions for the treatment of various diseases, particularly relating ...

Akeso's GHG Emissions Data Preview

In 2024, Akeso completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Akeso has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)202420232022
2021 - 2017
Total Scope 1
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Total Scope 2
Unspecified Calculation Method
Copy/Paste is a PRO feature.
0000000
Copy/Paste is a PRO feature.
c
0000000
Total Scope 3
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
0000000
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
c
0000000
Limited Data Preview
You are viewing a limited preview of Akeso’s GHG emissions dataset. The full dataset, available for download, includes Scope 1, 2, and 3 emissions with detailed category-level breakdowns, historical coverage back to 2022, and revenue-based intensity metrics for each scope.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=9926&reporting_period=2024"

Verified Sources Behind Akeso’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Akeso’s data sources below and access millions more through our Disclosure Search.

a. Akeso's ESG Report 2024
b. Akeso's ESG Report 2023
c. Akeso's ESG Report 2022

Insights into Akeso's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Akeso amounted to 52,428.27 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Akeso increased by 85.72%, suggesting that the company faced challenges in reducing its emissions from its core operations.ab

Akeso's Scope 1 Emissions Over Time

20222023202402 k4 k6 k8 ktCO2e+1604%+359%
  • Total Scope 1
  • Year-over-Year Change

What are Akeso's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Akeso were 6,408.46 metric tons of CO₂ equivalent (tCO₂e).a

Has Akeso reduced its Scope 1 emissions over time?

Since 2022, Akeso's Scope 1 emissions have increased by 7,715.2%, reflecting a rising long-term trend in Scope 1 emissions over time.ac

Compared to the previous year (2023), Akeso's Scope 1 emissions increased by 358.54%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.ab

What are Akeso's Scope 2 emissions?

In 2024, Akeso reported Scope 2 greenhouse gas (GHG) emissions of 46,019.81 tCO₂e using the location-based method.a

What methodology does Akeso use for Scope 2 reporting?

In 2024, Akeso reported its Scope 2 emissions using the location-based method.a

Akeso's Scope 2 Emissions Over Time

202220232024015 k30 k45 k60 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Akeso’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Akeso reported Scope 1 greenhouse gas (GHG) emissions of 6,408.46 tCO₂e and total revenues of USD 318 millions. This translates into an emissions intensity of 20.17 tCO₂e per millions USD.a

Akeso's Scope 1 Emissions Intensity Compared to Peers

0.5102005,000100,000Scope 1 Emissions (tCO2e)2202001,00010,000Revenues (Millions of USD)AASDInnoCare PharmaYear: 2023Scope 1: 20 tCO2eRevenue: $M 104Scope 1 Intensity: 0.19 tCO2e/$MAntengeneYear: 2023Scope 1: 45 tCO2eRevenue: $M 10Scope 1 Intensity: 4.37 tCO2e/$MShanghai Henlius BiotechYear: 2023Scope 1: 6,909 tCO2eRevenue: $M 830Scope 1 Intensity: 8.32 tCO2e/$MRemeGenYear: 2024Scope 1: 54 tCO2eRevenue: $M 234Scope 1 Intensity: 0.23 tCO2e/$MGenscript BiotechYear: 2024Scope 1: 39,377 tCO2eRevenue: $M 4,637Scope 1 Intensity: 8.49 tCO2e/$MAAAscentage PharmaYear: 2023Scope 1: 2,081 tCO2eRevenue: $M 34Scope 1 Intensity: 61.05 tCO2e/$MShanghai Junshi BiosciencesYear: 2024Scope 1: 5,308 tCO2eRevenue: $M 267Scope 1 Intensity: 19.88 tCO2e/$MEverest MedicinesYear: 2024Scope 1: 1 tCO2eRevenue: $M 106Scope 1 Intensity: 0.00 tCO2e/$MInnovent BiologicsYear: 2024Scope 1: 48 tCO2eRevenue: $M 1,409Scope 1 Intensity: 0.03 tCO2e/$MAAAurisco PharmaceuticalYear: 2024Scope 1: 2,731 tCO2eRevenue: $M 202Scope 1 Intensity: 13.51 tCO2e/$MCARsgen Therapeutics HoldingsYear: 2021Scope 1: 117 tCO2eRevenue: $M 4Scope 1 Intensity: 28.91 tCO2e/$MZai LabYear: 2023Scope 1: 15 tCO2eRevenue: $M 267Scope 1 Intensity: 0.06 tCO2e/$MSSSichuan Kelun-Biotech BiopharmaceuticalYear: 2023Scope 1: 6,335 tCO2eRevenue: $M 237Scope 1 Intensity: 26.78 tCO2e/$MDDDaShenLin Pharmaceutical GroupYear: 2024Scope 1: 5,220 tCO2eRevenue: $M 3,631Scope 1 Intensity: 1.44 tCO2e/$MZhifeiYear: 2024Scope 1: 13,576 tCO2eRevenue: $M 3,572Scope 1 Intensity: 3.80 tCO2e/$MKintor PharmaceuticalYear: 2021Scope 1: 29 tCO2eRevenue: $M 5Scope 1 Intensity: 5.35 tCO2e/$MAscletis PharmaYear: 2023Scope 1: 422 tCO2eRevenue: $M 9Scope 1 Intensity: 48.50 tCO2e/$M3SBioYear: 2024Scope 1: 13,304 tCO2eRevenue: $M 1,364Scope 1 Intensity: 9.75 tCO2e/$MVIVA Biotech HoldingsYear: 2022Scope 1: 1,404 tCO2eRevenue: $M 373Scope 1 Intensity: 3.76 tCO2e/$MPharmaron BeijingYear: 2024Scope 1: 34,268 tCO2eRevenue: $M 1,682Scope 1 Intensity: 20.37 tCO2e/$MJacobio Pharmaceuticals GroupYear: 2023Scope 1: 34 tCO2eRevenue: $M 10Scope 1 Intensity: 3.48 tCO2e/$MAsymchem Laboratories (Tianjin)Year: 2024Scope 1: 31,787 tCO2eRevenue: $M 795Scope 1 Intensity: 39.96 tCO2e/$MWuXi Biologics (Cayman)Year: 2024Scope 1: 38,346 tCO2eRevenue: $M 2,779Scope 1 Intensity: 13.80 tCO2e/$MAkesoYear: 2024Scope 1: 6,408 tCO2eRevenue: $M 318Scope 1 Intensity: 20.17 tCO2e/$M

How does Akeso's GHG emissions intensity compare to its peers?

In 2024, Akeso reported a Scope 1 emissions intensity of 20.17 tCO₂e per millions USD. Compared to the peer group median of 8.32, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a

Where does Akeso rank on GHG emissions intensity within its industry?

In 2024, Akeso ranked 18 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

Akeso is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a

Want Full Access to Akeso's GHG Emissions Dataset?
Start 30-Day Free Trial